Researcher
Benoit Beuselinck
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Feb 2011 → Today
Projects
1 - 6 of 6
- Response prediction in metastatic clear-cell renal cell carcinoma treated with angiogenesis and/or immune checkpoint inhibitorsFrom1 Oct 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Medication-related osteonecrosis of the jaw (MRONJ) - Balancing treatments benefits and risksFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- RESPONSE PREDICTION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TARGETED THERAPY AND/OR IMMUNE CHECKPOINT INHIBITORSFrom5 Dec 2019 → 30 Sep 2021Funding: BOF - projects
- RESPONSE PREDICTION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTORTARGETED THERAPY AND/OR IMMUNE CHECKPOINT INHIBITORSFrom1 Oct 2019 → TodayFunding: FWO fellowships
- Patient selection strategies throughout the renal cell carcinoma disease spectrumFrom1 Aug 2019 → 6 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular profiling of clear-cell renal cell carcinoma and prediction of response to targeted therapies against the vascular endothelial growth factor receptor, immune checkpoint inhibitors and mTOR inhibitors in the metastatic setting.From1 Oct 2016 → 30 Sep 2020Funding: FWO fellowships, Nonprofit institution or equivalents
Publications
11 - 20 of 152
- Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium(2023)
Authors: Benoit Beuselinck
Pages: 204 - 211 - Predicting short- and long-term renal function following partial and radical nephrectomy(2023)
Authors: Annouschka Laenen, Ben Van Cleynenbreugel, Ben Sprangers, Benoit Beuselinck, Hendrik Van Poppel, Steven Joniau, Maarten Albersen
Pages: 1100 - 110000000 - CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)(2023)
Authors: Benoit Beuselinck
- Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium(2023)
Authors: Benoit Beuselinck
Pages: 145 - 151 - PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer(2023)
Authors: Benoit Beuselinck
Pages: 2116 - 2125 - Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma(2023)
Authors: Lisa Kinget, Sarah Cappuyns, Chris Verslype, Benoit Beuselinck, Jeroen Dekervel
- Trial watch: Dendritic cell (DC)-based immunotherapy for cancer(2022)
Authors: Jenny Sprooten, Stefan Naulaerts, Benoit Beuselinck, An Coosemans, Lisa Kinget, Sandra Tuyaerts, Steven De Vleeschouwer, Abhishek Garg
- Incidence of Cardiovascular Events in Patients Treated With Immune Checkpoint Inhibitors(2022)
Authors: Yuling Yu, Beatrice Santens, Johanna Jacobs, Benoit Beuselinck, Oliver Bechter, Els Wauters, Jan A Staessen, Lucas Van Aelst
Pages: 3430 - + - Patient selection strategies throughout the renal cell carcinoma disease spectrum(2022)
Authors: Eduard Roussel, Maarten Albersen, Benoit Beuselinck
- Clearseq1-4 classifier in localized and metastatic clear-cell renal cell carcinoma (ccRCC)(2022)
Authors: Lisa Kinget, Diether Lambrechts, Bram Boeckx, Maarten Albersen, Benoit Beuselinck
Pages: S1222 - S1223